Nephros, Inc. (NASDAQ:NEPH) Short Interest Update

Nephros, Inc. (NASDAQ:NEPH) was the recipient of a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 2,600 shares, a drop of 25.7% from the September 15th total of 3,500 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 14,300 shares, the short-interest ratio is currently 0.2 days.

Nephros Price Performance

Shares of NEPH stock opened at $1.46 on Friday. The company has a market capitalization of $15.39 million, a price-to-earnings ratio of -11.23 and a beta of 1.18. Nephros has a one year low of $1.43 and a one year high of $4.04. The company’s fifty day moving average price is $1.81 and its 200-day moving average price is $2.04.

Nephros (NASDAQ:NEPH) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.02). The firm had revenue of $3.25 million for the quarter. Nephros had a negative net margin of 9.40% and a negative return on equity of 15.64%.

Institutional Trading of Nephros

A hedge fund recently bought a new stake in Nephros stock. Dimensional Fund Advisors LP purchased a new stake in Nephros, Inc. (NASDAQ:NEPH) during the second quarter, according to its most recent filing with the SEC. The fund purchased 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned about 0.17% of Nephros as of its most recent filing with the SEC. Hedge funds and other institutional investors own 41.10% of the company’s stock.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.